|
SAN DIEGO, Sept. 23, 2018 /PRNewswire/ -- Abbott (NYSE: ABT) today announced positive clinical study results from a randomized controlled trial comparing treatment with the MitraClip device to guideline-directed medical therapy in select patients with secondary (or functional) mitral...
Tags
advanced
study
shows
medical
Category:
Financial Services
All news |
||||||||||||||||||
|